mail
versión imprimible
 
 

Viral Vector Process Development Summit

Evvnt Promotion / evvnt
-
31.01.2023 - 02.02.2023  Omni Parker House, 60 School Street, 02108 Boston, Massachusetts, USA
Time: 9:00 am - 4:30 pm
 
Temas de la conferencia
As cell and gene therapy and genomic medicine pipeline continues to mature, process development for viral vector is becoming critical for drug developers for the next phase, to deliver a quality, transformative cure to patients with affordability.
La Sociedad Científica
Hanson Wade
Observaciones
URL:
Website: https://go.evvnt.com/1322215-3?pid=4832

Speakers: Rajiv Gangurde | Chief Technology Officer | SparingVision, Susan D'Costa | Executive VP and Global Head, Technology | Alcyone Therapeutics, and more.
 

Información e inscripción:

https://go.evvnt.com/1322215-2?pid=4832
Ms. Stephanie Nketia
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 2999.00 - USD 5396.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

European Public Health Association (EUPHA)Charité International AcademyÖsterreichische Akademie der ÄrzteAlumni Club Medizinische Universität WienCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioSwiss Tropical and Public Health InstituteCenter of ExcellenceÖsterreichische Gesellschaft für Public Health